Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Biologics dont need long market exclusivity, FTC says
American Medical News , 06/30/09

Trapp D - A recent Federal Trade Commission report asserting that original biopharmaceutical drug manufacturers do not need lengthy exclusive marketing periods to maintain innovation has not driven supporters from a bill that would extend such protection.

Related Articles

Nabi Biopharmaceuticals to Hold Conference Call
Nabi Biopharmaceuticals, 11/17/09    Relevance Score: 87%

Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
Bristol Myers-Squibb Company, 11/11/09    Relevance Score: 84%

Nabi Biopharmaceuticals Participates in NicVAX(R) Phase IIb Study
Nabi Biopharmaceuticals, 10/29/09    Relevance Score: 84%

Nabi Biopharmaceuticals to Announce Third Quarter Financial Results on November 2009
Nabi Biopharmaceuticals, 10/28/09    Relevance Score: 84%

Sanofi-aventis to acquire FOVEA, a French biopharmaceutical ophthalmology company
Sanofi-aventis, 10/02/09    Relevance Score: 84%

Today in Biotechnology...keeping you current

ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09

ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09

Expanding The Biopharmaceutical Industry's Involvement In Fighting Neglected Diseases
Health Affairs, 11/19/09

 See all of Biotechnology

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address